Fortekor Plus for Dogs
Fortekor Plus is positioned as a leading, practice-friendly option because it combines an ACE inhibitor with a diuretic into a single tablet to simplify chronic heart-failure regimens. That fixed-dose approach reduces pill burden and clinic dispensing complexity compared with single-agent generics, offering veterinarians a technically convenient and often cost-competitive solution for managing canine congestive heart failure. Relative to plain ACE inhibitor products on this list, its main financial advantage is lower overall dispensing cost and improved owner compliance when both modalities are indicated.
Dual heart support
Once-daily dosing
Dual heart support
Once-daily dosing
Review Summary
"Owners commonly report visible improvement in symptoms and bloodwork with long-term use; tablets are easy to administer though a minority note occasional vomiting or lethargy."
Vet-tested, tail-wiggly
Contains an ACE inhibitor combined with an inodilator to address both blood pressure and cardiac output in congestive heart failure.
Vet-tested, tail-wiggly
Contains an ACE inhibitor combined with an inodilator to address both blood pressure and cardiac output in congestive heart failure.
Increased Safety & Security
Time-Saving Convenience
Fortekor Plus is positioned as a leading, practice-friendly option because it combines an ACE inhibitor with a diuretic into a single tablet to simplify chronic heart-failure regimens. That fixed-dose approach reduces pill burden and clinic dispensing complexity compared with single-agent generics, offering veterinarians a technically convenient and often cost-competitive solution for managing canine congestive heart failure. Relative to plain ACE inhibitor products on this list, its main financial advantage is lower overall dispensing cost and improved owner compliance when both modalities are indicated.
Dual heart support
Once-daily dosing
Vet-tested, tail-wiggly
Contains an ACE inhibitor combined with an inodilator to address both blood pressure and cardiac output in congestive heart failure.
Designed for once- or twice-daily oral dosing under veterinary prescription with formulations matched to dog weight ranges.
Dual heart support
Once-daily dosing
Vet-tested, tail-wiggly
Contains an ACE inhibitor combined with an inodilator to address both blood pressure and cardiac output in congestive heart failure.
Designed for once- or twice-daily oral dosing under veterinary prescription with formulations matched to dog weight ranges.
$120-220 CAD
Enacard Tablets
Enacard is a widely used enalapril product known for consistent pharmacokinetics and a long clinical track record in canine hypertension and heart disease, which helps practice confidence when compared to newer or combined formulations. It typically offers lower upfront cost than premium branded combos while delivering predictable ACE inhibition, making it a practical baseline therapy for many patients. Compared to generics, Enacard often comes with stronger veterinary support programs and dosing literature that can reduce monitoring time in busy clinics.
Blood pressure control
Kidney-friendly dose
Blood pressure control
Kidney-friendly dose
Review Summary
"Most users find Enacard effective for managing hypertension and heart disease in dogs; some dogs experience mild side effects such as decreased appetite or gastrointestinal upset."
Pill-palatable perk
Enalapril is a widely used ACE inhibitor for managing canine hypertension and heart failure by reducing vascular resistance.
Pill-palatable perk
Enalapril is a widely used ACE inhibitor for managing canine hypertension and heart failure by reducing vascular resistance.
Increased Safety & Security
Enacard is a widely used enalapril product known for consistent pharmacokinetics and a long clinical track record in canine hypertension and heart disease, which helps practice confidence when compared to newer or combined formulations. It typically offers lower upfront cost than premium branded combos while delivering predictable ACE inhibition, making it a practical baseline therapy for many patients. Compared to generics, Enacard often comes with stronger veterinary support programs and dosing literature that can reduce monitoring time in busy clinics.
Blood pressure control
Kidney-friendly dose
Pill-palatable perk
Enalapril is a widely used ACE inhibitor for managing canine hypertension and heart failure by reducing vascular resistance.
Available in multiple tablet strengths for flexible dosing, usually administered once or twice daily as directed by a veterinarian.
Blood pressure control
Kidney-friendly dose
Pill-palatable perk
Enalapril is a widely used ACE inhibitor for managing canine hypertension and heart failure by reducing vascular resistance.
Available in multiple tablet strengths for flexible dosing, usually administered once or twice daily as directed by a veterinarian.
$45-95 CAD
Benazepril HCl Tablets
Benazepril HCl tablets represent the generic, best-value entry in ACE inhibitor therapy and are chosen primarily for affordability and wide availability across formularies. Their technical advantage is interchangeability and flexible dosing across many sizes, which can decrease long-term medication spend versus branded alternatives, though they may lack the additional support services offered by some manufacturers. For clinics focused on cost management in chronic cardiovascular care, benazepril generics are often the most economical foundational ACE inhibitor.
Long-lasting action
Tablet-splittable
Long-lasting action
Tablet-splittable
Review Summary
"Generic benazepril is praised for similar effectiveness to brand-name ACE inhibitors at a lower cost, with reliable long-term control and only occasional side-effect reports."
Mild aroma — sniff-approved
Generic benazepril offers an affordable ACE inhibitor option for chronic management of canine heart disease and hypertension.
Mild aroma — sniff-approved
Generic benazepril offers an affordable ACE inhibitor option for chronic management of canine heart disease and hypertension.
Increased Safety & Security
Self-Improvement & Personal Growth
Benazepril HCl tablets represent the generic, best-value entry in ACE inhibitor therapy and are chosen primarily for affordability and wide availability across formularies. Their technical advantage is interchangeability and flexible dosing across many sizes, which can decrease long-term medication spend versus branded alternatives, though they may lack the additional support services offered by some manufacturers. For clinics focused on cost management in chronic cardiovascular care, benazepril generics are often the most economical foundational ACE inhibitor.
Long-lasting action
Tablet-splittable
Mild aroma — sniff-approved
Generic benazepril offers an affordable ACE inhibitor option for chronic management of canine heart disease and hypertension.
Typically dosed once daily and available in several strengths to accommodate different dog sizes and treatment plans.
Long-lasting action
Tablet-splittable
Mild aroma — sniff-approved
Generic benazepril offers an affordable ACE inhibitor option for chronic management of canine heart disease and hypertension.
Typically dosed once daily and available in several strengths to accommodate different dog sizes and treatment plans.
$30-80 CAD
Vetmedin Chewable Tablets
Vetmedin (pimobendan) is a market leader in canine cardiac care as a positive inotrope and vasodilator frequently used alongside ACE inhibitors to improve clinical outcomes in congestive heart failure. Although not an ACE inhibitor itself, its clear survival and quality-of-life benefits make it a standard complementary therapy to the ACE products listed here, and its established efficacy can reduce downstream treatment costs by stabilizing patients more quickly. Practically, clinicians favor pairing Vetmedin with ACE inhibitors for a combined pharmacologic strategy rather than as a standalone blood-pressure agent.
Heart strength boost
Chewable flavored
Heart strength boost
Chewable flavored
Review Summary
"Vetmedin chewables are frequently described as life-changing for dogs with congestive heart failure, improving energy and appetite; a small percentage report diarrhea or reluctance to eat the tablets."
Energy return — zoom!
Pimobendan (Vetmedin) is a leading inodilator that enhances cardiac contractility and causes vasodilation in dogs with heart failure.
Energy return — zoom!
Pimobendan (Vetmedin) is a leading inodilator that enhances cardiac contractility and causes vasodilation in dogs with heart failure.
Increased Safety & Security
Vetmedin (pimobendan) is a market leader in canine cardiac care as a positive inotrope and vasodilator frequently used alongside ACE inhibitors to improve clinical outcomes in congestive heart failure. Although not an ACE inhibitor itself, its clear survival and quality-of-life benefits make it a standard complementary therapy to the ACE products listed here, and its established efficacy can reduce downstream treatment costs by stabilizing patients more quickly. Practically, clinicians favor pairing Vetmedin with ACE inhibitors for a combined pharmacologic strategy rather than as a standalone blood-pressure agent.
Heart strength boost
Chewable flavored
Energy return — zoom!
Pimobendan (Vetmedin) is a leading inodilator that enhances cardiac contractility and causes vasodilation in dogs with heart failure.
Available as palatable chewable tablets to aid administration and commonly used alongside ACE inhibitors for congestive heart disease.
Heart strength boost
Chewable flavored
Energy return — zoom!
Pimobendan (Vetmedin) is a leading inodilator that enhances cardiac contractility and causes vasodilation in dogs with heart failure.
Available as palatable chewable tablets to aid administration and commonly used alongside ACE inhibitors for congestive heart disease.
$160-320 CAD
Cardalis Tablets
Cardalis is presented as a premium ACE inhibitor option aimed at clinics that prioritize formulation variety and manufacturer-backed practice support, offering packaged dosing options and supply-chain reliability that can justify a higher per-tablet price. Its niche is in providing predictable product availability and additional veterinary resources, which some practices find reduces administrative overhead compared with sourcing multiple generics. Compared with the more economical benazepril generics or single-agent enalapril, Cardalis trades a higher unit cost for convenience, consistent supply, and vendor service.
Combo therapy
Stable blood pressure
Combo therapy
Stable blood pressure
Review Summary
"Cardalis (combination therapy) is valued for convenience and good symptom control in chronic cardiac patients, though reviewers commonly note the need for electrolyte and kidney monitoring."
Two-in-one convenience — hooray
Combination tablet pairing an ACE inhibitor with pimobendan to target both neurohormonal activation and reduced cardiac output.
Two-in-one convenience — hooray
Combination tablet pairing an ACE inhibitor with pimobendan to target both neurohormonal activation and reduced cardiac output.
Increased Safety & Security
Time-Saving Convenience
Cardalis is presented as a premium ACE inhibitor option aimed at clinics that prioritize formulation variety and manufacturer-backed practice support, offering packaged dosing options and supply-chain reliability that can justify a higher per-tablet price. Its niche is in providing predictable product availability and additional veterinary resources, which some practices find reduces administrative overhead compared with sourcing multiple generics. Compared with the more economical benazepril generics or single-agent enalapril, Cardalis trades a higher unit cost for convenience, consistent supply, and vendor service.
Combo therapy
Stable blood pressure
Two-in-one convenience — hooray
Combination tablet pairing an ACE inhibitor with pimobendan to target both neurohormonal activation and reduced cardiac output.
Helps reduce pill burden by delivering two complementary therapies in one prescribed formulation tailored to canine dosing.
Combo therapy
Stable blood pressure
Two-in-one convenience — hooray
Combination tablet pairing an ACE inhibitor with pimobendan to target both neurohormonal activation and reduced cardiac output.
Helps reduce pill burden by delivering two complementary therapies in one prescribed formulation tailored to canine dosing.
$130-260 CAD